RankingsPricing
  1. US-listed companies
  2. Bionik Laboratories Corp.

Bionik Laboratories Corp.BNKL

Market cap
$12.48
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2015		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023
Net loss-----25-13,620,457-10,407,994-4,946,024
Depreciation and amortization------189,730102,62363,167
Interest expense-182--41,934-1,294,005-255,833-176,593-406,384-822,568-105,794
Issuance of common shares in lieu of services-------53,80068,200
Extinguishment of debt-------459,912-
Goodwill and Intangible Asset Impairment------75-
Write-off of demonstration equipment-----94,641-16,248-
Share based compensation expense--844,162212819,213384,365308,305
Accounts receivable-79-377,413-190,8671-508,729-395,059-177,062178,240
Prepaid expenses and other current assets-107,087-20,525205,608921,377277,52348,002-553,266-263,953
Operating leases, net--------1,863
Inventories--39,3709,194168,239653,780-332,456543,957-78,373
Accounts payable--174,229-332,010-60,098424,179-291,759-407,875-148,960262,238
Accrued liabilities332-97,62318,674304,048122,928-5,577153,776104,495509,912
Deferred revenue--98,62424,043345,111148,285-44,063-1,49975,145
Net cash used in operating activities-4,250---7,710,862-9,232,411-9,063,554-4,623,886-4,147,287-3,387,314
Acquisition--------215,000
Purchases of equipment-80,195170,79021,567101,779159,645---
Other non-current assets--------8,694
Net cash used in investing activities----21,567-101,779-159,645--12,500-223,694
Proceeds from Convertible Debt--2792262
Net cash provided by financing activities23,850--8911362
Foreign exchange impact--------7,184-2,986
Net (decrease)/increase in cash and cash equivalents-------1-1,563,994
Subsidiary purchase of fixed assets--------50,185
Conversion of term loans into option exercises-------642,153-
Transfer of demonstration equipment from inventory to fixed assets------34,84342,768-
Conversion of promissory notes into common stock------29-